MAPT and Alzheimer disease: G-protein-coupled receptors (GPCRs) play a crucial role in Alzheimer’s disease (AD) pathophysiology, including promoting Aβ and tau accumulation, driving neuroinflammation, and impairing synaptic dysfunction [40–42].